Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Mar;105(3):675–678. doi: 10.1111/j.1476-5381.1992.tb09037.x

Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.

M R Zarrindast 1, A Jamshidzadeh 1
PMCID: PMC1908467  PMID: 1385751

Abstract

1. Bromocriptine (2, 4 and 8 mg kg-1, i.p.), physostigmine (0.05, 0.1 and 0.2 mg kg-1, i.p.) and pilocarpine (1, 3 and 5 mg kg-1, i.p.) induced dose-dependent yawning in rats. 2. These responses were reduced in a dose-dependent manner by pretreatment with morphine. 3. The inhibitory effect of morphine was reversed by naloxone. 4. Naloxone alone induced slight but significant yawning. 5. The present results suggest that morphine inhibits yawning in rats at an opiate receptor downstream from the sites at which cholinoceptor and dopamine D2 activation induce yawning. The anatomical location of these sites remains to be established.

Full text

PDF
675

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agid Y., Guyenet P., Glowinski J., Beaujouan J. C., Javoy F. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat. Brain Res. 1975 Mar 28;86(3):488–492. doi: 10.1016/0006-8993(75)90901-4. [DOI] [PubMed] [Google Scholar]
  2. Ahtee L., Käriäinen I. The effect of narcotic analgesics on the homovanillic acid content of rat nucleus caudatus. Eur J Pharmacol. 1973 May;22(2):206–208. doi: 10.1016/0014-2999(73)90014-9. [DOI] [PubMed] [Google Scholar]
  3. BARBIZET J. Yawning. J Neurol Neurosurg Psychiatry. 1958 Aug;21(3):203–209. doi: 10.1136/jnnp.21.3.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BUTCHER R. W., SUTHERLAND E. W. Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem. 1962 Apr;237:1244–1250. [PubMed] [Google Scholar]
  5. Baggio G., Ferrari F. The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats. Psychopharmacology (Berl) 1983;80(1):38–42. doi: 10.1007/BF00427492. [DOI] [PubMed] [Google Scholar]
  6. Biggio G., Casu M., Corda M. G., Di Bello C., Gessa G. L. Stimulation of dopamine synthesis in caudate nucleus by intrastriatal enkephalins and antagonism by naloxone. Science. 1978 May 5;200(4341):552–554. doi: 10.1126/science.205949. [DOI] [PubMed] [Google Scholar]
  7. Costa E., Cheney D. L., Racagni G., Zsilla G. An analysis at synaptic level of the morphine action in striatum and N. accumbens: dopamine and acetylcholine interactions. Life Sci. 1975 Jul 1;17(1):1–8. doi: 10.1016/0024-3205(75)90223-4. [DOI] [PubMed] [Google Scholar]
  8. Di Chiara G., Porceddu M. L., Vargiu L., Argiolas A., Gessa G. L. Evidence for dopamine receptors mediating sedation in the mouse brain. Nature. 1976 Dec 9;264(5586):564–567. doi: 10.1038/264564a0. [DOI] [PubMed] [Google Scholar]
  9. Dourish C. T., Hutson P. H. Bilateral lesions of the striatum induced with 6-hydroxydopamine abolish apomorphine-induced yawning in rats. Neuropharmacology. 1985 Nov;24(11):1051–1055. doi: 10.1016/0028-3908(85)90190-x. [DOI] [PubMed] [Google Scholar]
  10. Gauchy C., Agid Y., Glowinski J., Cheramy A. Acute effects of morphine on dopamine synthesis and release and tyrosine metabolism in the rat striatum. Eur J Pharmacol. 1973 Jun;22(3):311–319. doi: 10.1016/0014-2999(73)90031-9. [DOI] [PubMed] [Google Scholar]
  11. Govoni S., Petkov V. V., Montefusco O., Missale C., Battaini F., Spano P. F., Trabucchi M. Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures. J Pharm Pharmacol. 1984 Jul;36(7):458–460. doi: 10.1111/j.2042-7158.1984.tb04425.x. [DOI] [PubMed] [Google Scholar]
  12. Guyenet P. G., Javory A. F., Beaujouan J. C., Rossier B. J., Glowinski J. Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system. Brain Res. 1975 Feb 7;84(2):227–244. doi: 10.1016/0006-8993(75)90978-6. [DOI] [PubMed] [Google Scholar]
  13. Iyengar S., Kim H. S., Wood P. L. Agonist action of the agonist/antagonist analgesic butorphanol on dopamine metabolism in the nucleus accumbens of the rat. Neurosci Lett. 1987 Jun 15;77(2):226–230. doi: 10.1016/0304-3940(87)90591-x. [DOI] [PubMed] [Google Scholar]
  14. Jhamandas K., Hron V., Sutak M. Comparative effects of opiate agonists methadone, levorphanol, and their isomers on the release of cortical ACh in vivo and in vitro. Can J Physiol Pharmacol. 1975 Aug;53(4):540–548. doi: 10.1139/y75-076. [DOI] [PubMed] [Google Scholar]
  15. Kim H. S., Iyengar S., Wood P. L. Opiate actions on mesocortical dopamine metabolism in the rat. Life Sci. 1986 Nov 24;39(21):2033–2036. doi: 10.1016/0024-3205(86)90327-9. [DOI] [PubMed] [Google Scholar]
  16. Laping N. J., Ramirez V. D. Prolactin-induced yawning behavior requires an intact nigro-striatal dopamine system. Pharmacol Biochem Behav. 1988 Jan;29(1):59–62. doi: 10.1016/0091-3057(88)90273-0. [DOI] [PubMed] [Google Scholar]
  17. Llorens-Cortes C., Pollard H., Schwartz J. C. Localization of opiate receptors in substantia nigra evidence by lesion studies. Neurosci Lett. 1979 May;12(2-3):165–170. doi: 10.1016/0304-3940(79)96056-7. [DOI] [PubMed] [Google Scholar]
  18. Mogilnicka E., Boissard C. G., Delini-Stula A. Effects of apomorphine, TL-99 and 3-PPP on yawning in rats. Neuropharmacology. 1984 Jan;23(1):19–22. doi: 10.1016/0028-3908(84)90211-9. [DOI] [PubMed] [Google Scholar]
  19. Mogilnicka E., Klimek V. Drugs affecting dopamine neurons and yawning behavior. Pharmacol Biochem Behav. 1977 Oct;7(4):303–305. doi: 10.1016/0091-3057(77)90224-6. [DOI] [PubMed] [Google Scholar]
  20. Morelli M., Longoni R., Spina L., Di Chiara G. Antagonism of apomorphine-induced yawning by SCH 23390: evidence against the autoreceptor hypothesis. Psychopharmacology (Berl) 1986;89(2):259–260. doi: 10.1007/BF00310640. [DOI] [PubMed] [Google Scholar]
  21. Pollard H., Llorens-Cortes C., Schwartz J. C. Enkephalin receptors on dopaminergic neurones in rat striatum. Nature. 1977 Aug 25;268(5622):745–747. doi: 10.1038/268745a0. [DOI] [PubMed] [Google Scholar]
  22. Protais P., Dubuc I., Costentin J. Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats. Eur J Pharmacol. 1983 Oct 28;94(3-4):271–280. doi: 10.1016/0014-2999(83)90416-8. [DOI] [PubMed] [Google Scholar]
  23. Sawynok J., Sweeney M. I., White T. D. Adenosine release may mediate spinal analgesia by morphine. Trends Pharmacol Sci. 1989 May;10(5):186–189. doi: 10.1016/0165-6147(89)90235-6. [DOI] [PubMed] [Google Scholar]
  24. Stoessl A. J., Dourish C. T., Iversen S. D. Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra. Psychopharmacology (Berl) 1987;93(3):336–342. doi: 10.1007/BF00187253. [DOI] [PubMed] [Google Scholar]
  25. Storm-Mathisen J. Localization of transmitter candidates in the brain: the hippocampal formation as a model. Prog Neurobiol. 1977;8(2):119–181. doi: 10.1016/0301-0082(77)90013-2. [DOI] [PubMed] [Google Scholar]
  26. Urbá-Holmgren R., González R. M., Holmgren B. Is yawning a cholinergic response? Nature. 1977 May 19;267(5608):261–262. doi: 10.1038/267261a0. [DOI] [PubMed] [Google Scholar]
  27. Wood P. L. Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences. Peptides. 1983 Sep-Oct;4(5):595–601. doi: 10.1016/0196-9781(83)90003-7. [DOI] [PubMed] [Google Scholar]
  28. Wood P. L., Richard J. W. Morphine and nigrostriatal function in the rat and mouse: the role of nigral and striatal opiate receptors. Neuropharmacology. 1982 Dec;21(12):1305–1310. doi: 10.1016/0028-3908(82)90138-1. [DOI] [PubMed] [Google Scholar]
  29. Wood P. L., Stotland M., Richard J. W., Rackham A. Actions of mu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function. J Pharmacol Exp Ther. 1980 Dec;215(3):697–703. [PubMed] [Google Scholar]
  30. Yamada K., Furukawa T. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psychopharmacology (Berl) 1980 Jan;67(1):39–43. doi: 10.1007/BF00427593. [DOI] [PubMed] [Google Scholar]
  31. Yamada K., Tanaka M., Shibata K., Furukawa T. Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats. Psychopharmacology (Berl) 1986;90(1):9–13. doi: 10.1007/BF00172863. [DOI] [PubMed] [Google Scholar]
  32. Yonehara N., Clouet D. H. Effects of delta and mu opiopeptides on the turnover and release of dopamine in rat striatum. J Pharmacol Exp Ther. 1984 Oct;231(1):38–42. [PubMed] [Google Scholar]
  33. Zarrindast M. R., Poursoltan M. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine. Br J Pharmacol. 1989 Apr;96(4):843–848. doi: 10.1111/j.1476-5381.1989.tb11893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES